Shanghai Medicilon Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 2,504

Employees

  • Stock Symbol
  • 688202

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $9.42
  • (As of Friday Closing)

Shanghai Medicilon General Information

Description

Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. 585 Chuanda Road
  • Pudong New Area
  • Shanghai, 201299
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • No. 585 Chuanda Road
  • Pudong New Area
  • Shanghai, 201299
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shanghai Medicilon Stock Performance

As of 20-Nov-2026, Shanghai Medicilon’s stock price is $9.42. Its current market cap is $1.27B with 134M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.42 $10.11 $7.28 - $17.91 $1.27B 134M 6.33M -$0.05

Shanghai Medicilon Financials Summary

As of 30-Sep-2026, Shanghai Medicilon has a trailing 12-month revenue of $223M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,118,681 1,056,305 506,080 1,204,244
Revenue 222,709 161,731 144,624 193,025
EBITDA (6,165) (9,669) (37,551) 6,849
Net Income (6,695) (23,338) (46,108) (4,694)
Total Assets 433,235 374,759 386,743 460,718
Total Debt 31,762 35,365 47,407 54,013
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Shanghai Medicilon Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shanghai Medicilon‘s full profile, request access.

Request a free trial

Shanghai Medicilon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range
Drug Discovery
Shanghai, China
2,504 As of 2025

Hyderabad, India
 

Nanjing, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Shanghai Medicilon Competitors (30)

One of Shanghai Medicilon’s 30 competitors is Aragen Life Sciences, a Private Equity-Backed company based in Hyderabad, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aragen Life Sciences Private Equity-Backed Hyderabad, India
GenScript Formerly VC-backed Nanjing, China
WuXi Biologics Formerly VC-backed Wuxi, China
Personalis Formerly VC-backed Fremont, CA
ChemPartner Formerly PE-Backed Shanghai, China
You’re viewing 5 of 30 competitors. Get the full list »

Shanghai Medicilon Patents

Shanghai Medicilon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026184756-A1 Crystal form of kif18a inhibitor drug, and preparation method therefor and use thereof Pending 07-Mar-2025
WO-2026061544-A1 Rnai formulation and use thereof Pending 23-Sep-2024
WO-2023216707-A1 Universal preclinical bio-distribution detection kit for nk cell therapy products Inactive 09-May-2022
US-20250361559-A1 Universal preclinical bio-distribution kit for nk cell therapy products Pending 09-May-2022
US-20250177542-A1 Preparation method for drug linker conjugate Pending 26-Jan-2022 A61K47/64
To view Shanghai Medicilon’s complete patent history, request access »

Shanghai Medicilon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shanghai Medicilon Acquisitions (2)

Shanghai Medicilon’s most recent deal was a Merger/Acquisition with Meibang Qili. The deal was made on 12-Aug-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Meibang Qili 12-Aug-2020 Merger/Acquisition Other Healthcare Technology Systems
Bestlinkage NHI 05-Jul-2017 Merger/Acquisition Real Estate Services (B2C)
To view Shanghai Medicilon’s complete acquisitions history, request access »

Shanghai Medicilon ESG

Risk Overview

Risk Rating

Updated February, 29, 2024

19.51 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Pharmaceuticals

Industry

of 952

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 70

Rank

Percentile

To view Shanghai Medicilon’s complete esg history, request access »

Shanghai Medicilon Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Meibang Qili Shanghai, China 2007

Shanghai Medicilon FAQs

  • When was Shanghai Medicilon founded?

    Shanghai Medicilon was founded in 2004.

  • Where is Shanghai Medicilon headquartered?

    Shanghai Medicilon is headquartered in Shanghai, China.

  • What is the size of Shanghai Medicilon?

    Shanghai Medicilon has 2,504 total employees.

  • What industry is Shanghai Medicilon in?

    Shanghai Medicilon’s primary industry is Drug Discovery.

  • Is Shanghai Medicilon a private or public company?

    Shanghai Medicilon is a Public company.

  • What is Shanghai Medicilon’s stock symbol?

    The ticker symbol for Shanghai Medicilon is 688202.

  • What is the current stock price of Shanghai Medicilon?

    As of 20-Nov-2026 the stock price of Shanghai Medicilon is $9.42.

  • What is the current market cap of Shanghai Medicilon?

    The current market capitalization of Shanghai Medicilon is $1.27B.

  • What is Shanghai Medicilon’s current revenue?

    The trailing twelve month revenue for Shanghai Medicilon is $223M.

  • Who are Shanghai Medicilon’s competitors?

    Aragen Life Sciences, GenScript, WuXi Biologics, Personalis, and ChemPartner are some of the 30 competitors of Shanghai Medicilon.

  • What is Shanghai Medicilon’s annual earnings per share (EPS)?

    Shanghai Medicilon’s EPS for 12 months was -$0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process